New Stock Alert CAEH.OB

****CAEH.OB Caleco Pharma Corp., CAEH.OB****

 

 

If you received our email earlier today you knew we had an exciting stock play for our subscribers coming after the bell.

CAEH is what all the excitement is about!

 

CAEH is developing its proprietary technology designed to treat moderate to severe liver maladies, including Hepatitis C viral infection.

CAEH’s treatment the “Liver Health Formula” is an over-the-counter medication that has already been Approved by the United States Food and Drug Administration (”FDA”).

To inform some of our subscribers of the opportunity in the Hepatitis C market, we have provided a few interesting factoids.

Hepatitis C is an infection of the liver caused by the Hepatitis C virus (HCV).

In the U.S., more than three million people are chronically infected with HCV.

HCV is the leading cause of liver transplantation in the U.S and is a risk factor for liver cancer.

An estimated 270-300 million people worldwide are infected with Hepatitis C.

CAEH`s management team has over 100 years of combined experience, which will assist them in bringing treatments to the market.

On January 21st, CAEH announced a Corporate Alliance with Rearden Health Partners. Our Researchers feel that this is a major step forward for the company.

The management team at Rearden have launched over 100 prescription and OTC products over the last 25 years, and are extremely well versed when it comes to new products. This will aid in increasing the value of CAEH, growing product pipelines and helping bring innovative products to the market.

 Now that you realize how much of an opportunity this liver treatment is, let me draw your eyes to some other interesting products the company has, or is developing.

 

 

 

CAEH`s diverse product line will allow them to take full advantage of many of the growth industries seen around the globe. The company also operates in the following growing markets:

  • Nutritional Supplements
  • Natural Skin Care
  • Natural Hair Care
  • Energy Drinks

Each one of these markets is a multi-billion dollar industry with growth potential in the near future! 

On top of those valid fundamental points, the company appears to be on the brink of a technical breakout.

CAEH is undergoing some healthy consolidation after the stock walked up to $0.35; it appears as though it is working on the right side of a base that hit bottom in the middle of December.   Last week our writers saw increased volume as the stock began inching up. 

 CAEH pulled back today, retesting interim lows in the $0.21-$0.22 range on significantly less volume.  This should be a great entry point for traders looking for a buying opportunity!

We also saw strong support that can be seen through the use of trend lines. 

The stock’s MACD lines, another key technical indicator, are converging and are now positive!

http://bigcharts.marketwatch.com/interchart/interchart.asp?symb=caeh&time=&freq=

On the upside, the stock should see little resistance before the $0.34-$0.35 mark.

If the stock can break out of that resistance point, we should see strong upward pressure from other technical traders.

Now that CAEH’s technical and fundamental pictures are both coming into place, we could see a powerful move in the near future!

Keep your eyes on CAEH!!!

About Caleco Pharma Corp.

Caleco Pharma is focused on the ongoing research and development of its broad pipeline of over-the-counter and prescription medications including its proprietary “Liver Health Formula” technology designed to treat moderate to severe liver maladies, including Hepatitis C viral infection. In addition Caleco Pharma is developing Food Supplements and over-the-counter Dermatological Products based on the active ingredients found in the Liver Health Formula. To date, Caleco Pharma’s intellectual property covering the Liver Health Formula comprises of patent applications in the United States, Europe and Canada and four European Drug Master File applications.

Caleco Pharma’s shares are traded in the United States on the OTC Bulletin Board (CAEH) and in Germany on the Frankfurt Stock Exchange (T3R)(WKN: A0N9Y0).

 

 

Begin your research on CAEH today!

CAEH information can be found at http://www.calecopharmacorp.com/

For additional information:

http://finance.yahoo.com/q?s=CAEH.OB

http://bigcharts.marketwatch.com/interchart/interchart.asp?symb=caeh&time=&freq=

http://quotes.barchart.com/texpert.asp?code=XDAILY&what=quote&sym=CAEH

Subscribe to SMS

By confirming my cell number, I agree that I am responsible for all of my carrier text messaging charges.